» Articles » PMID: 23334599

Early-onset Cataracts, Spastic Paraparesis, and Ataxia Caused by a Novel Mitochondrial TRNAGlu (MT-TE) Gene Mutation Causing Severe Complex I Deficiency: a Clinical, Molecular, and Neuropathologic Study

Overview
Specialties Neurology
Pathology
Date 2013 Jan 22
PMID 23334599
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial respiratory chain disease is associated with a spectrum of clinical presentations and considerable genetic heterogeneity. Here we report molecular genetic and neuropathologic findings from an adult with an unusual manifestation of mitochondrial DNA disease. Clinical features included early-onset cataracts, ataxia, and progressive paraparesis, with sequencing revealing the presence of a novel de novo m.14685G>A mitochondrial tRNA(Glu) (MT-TE) gene mutation. Muscle biopsy showed that 13% and 34% of muscle fibers lacked cytochrome c oxidase activity and complex I subunit expression, respectively. Biochemical studies confirmed a marked decrease in complex I activity. Neuropathologic investigation revealed a large cystic lesion affecting the left putamen, caudate nucleus, and internal capsule, with evidence of marked microvacuolation, neuron loss, perivascular lacunae, and blood vessel mineralization. The internal capsule showed focal axonal loss, whereas brainstem and spinal cord showed descending anterograde degeneration in medullary pyramids and corticospinal tracts. In agreement with muscle biopsy findings, reduced complex I immunoreactivity was detected in the remaining neuronal populations, particularly in the basal ganglia and cerebellum, correlating with the neurologic dysfunction exhibited by the patient. This study emphasizes the importance of molecular genetic and postmortem neuropathologic analyses for furthering our understanding of underlying mechanisms of mitochondrial disorders.

Citing Articles

Whole mitogenome sequencing uncovers a relation between mitochondrial heteroplasmy and leprosy severity.

Gouvea de Souza F, da Silva M, de Araujo G, Silva C, Pinheiro A, Caceres-Duran M Hum Genomics. 2023; 17(1):110.

PMID: 38062538 PMC: 10704783. DOI: 10.1186/s40246-023-00555-8.


Comprehensive summary of mitochondrial DNA alterations in the postmortem human brain: A systematic review.

Valiente-Palleja A, Tortajada J, Bulduk B, Vilella E, Garrabou G, Muntane G EBioMedicine. 2022; 76:103815.

PMID: 35085849 PMC: 8790490. DOI: 10.1016/j.ebiom.2022.103815.


Involvement of the Spinal Cord in Mitochondrial Disorders.

Finsterer J, Zarrouk-Mahjoub S J Neurosci Rural Pract. 2018; 9(2):245-251.

PMID: 29725177 PMC: 5912032. DOI: 10.4103/jnrp.jnrp_446_17.


De novo mtDNA point mutations are common and have a low recurrence risk.

Sallevelt S, de Die-Smulders C, Hendrickx A, Hellebrekers D, De Coo I, Alston C J Med Genet. 2016; 54(2):73-83.

PMID: 27450679 PMC: 5502310. DOI: 10.1136/jmedgenet-2016-103876.


A mutation in the THG1L gene in a family with cerebellar ataxia and developmental delay.

Edvardson S, Elbaz-Alon Y, Jalas C, Matlock A, Patel K, Labbe K Neurogenetics. 2016; 17(4):219-225.

PMID: 27307223 DOI: 10.1007/s10048-016-0487-z.